WorksheetsDisease Prevention and Health Promotion (Part 1)
Total questions: 60
Worksheet time: 30mins
Name
Class
Date
1.
These are unicellular parasites
a)
Fungi
b)
Metazoa
c)
Protozoa
d)
Bacteria
2.
Common examples of these pathogenic agents are Plasmodia and Amoeba
a)
Fungi
b)
Metazoa
c)
Protozoa
d)
Bacteria
3.
Common diseases associated with these pathogenic agents are jock itch, candidiasis and ringworm
a)
Fungi
b)
Metazoa
c)
Protozoa
d)
Bacteria
4.
Commonly treated with Albendazole and Pyrantel pamoate
a)
Fungi
b)
Metazoa
c)
Protozoa
d)
Bacteria
5.
These are the smallest biologic agent
a)
Virus
b)
Fungi
c)
Rickettsia
d)
Bacteria
6.
Commonly called as the "Rocky Mountain Fever" caused by a tick which infects the endothelial cells of the blood vessels
a)
Virus
b)
Fungi
c)
Rickettsia
d)
Bacteria
7.
It is the disease phase where the interaction between the host, the agent and other factors before the agent contacts with the host.
a)
Pre-pathogenic phase
b)
Pathogenic phase
8.
Disease phase where:
invasion -> incubation -> clinical horizon -> recovery/disability/death.
invasion -> incubation -> clinical horizon -> recovery/disability/death.
a)
Pre-pathogenic phase
b)
Pathogenic phase
9.
Also known as the phase of "host-agent interaction"
a)
Pre-pathogenic phase
b)
Pathogenic phase
10.
All are requirements of a host for a successful invasion of the agent, except:
a)
Favorable environment
b)
Immunity of the host
c)
Sustainable reservoir
d)
Portal of entry/exit of the agent
11.
All are manifestation of a host-agent relationship, except:
a)
Dosage of the agent
b)
Duration of exposure of the host
c)
Portal of entry of the agent
d)
Reaction of the agent's tissue to the host
12.
Reaction of the host when infected:
Natural resistance, acquired immunity, state of good health etc. or can be due to weak or smaller dosage.
Natural resistance, acquired immunity, state of good health etc. or can be due to weak or smaller dosage.
a)
The host successfully wards of the pathogen
b)
Balanced equilibrium
c)
Subclinical conditions
d)
Full-blown clinical cases
13.
Reaction of the host when infected:
The force of agent and host are equal so both are not affected. (Host become a carrier which can easily spread the disease and evade detection)
The force of agent and host are equal so both are not affected. (Host become a carrier which can easily spread the disease and evade detection)
a)
The host successfully wards of the pathogen
b)
Balanced equilibrium
c)
Subclinical conditions
d)
Full-blown clinical cases
14.
Reaction of the host when infected:
Very mild that they escape detection. (Host is a carrier state)
Very mild that they escape detection. (Host is a carrier state)
a)
The host successfully wards of the pathogen
b)
Balanced equilibrium
c)
Subclinical conditions
d)
Full-blown clinical cases
15.
Reaction of the host when infected:
The condition of the host can be typical or atypical
The condition of the host can be typical or atypical
a)
The host successfully wards of the pathogen
b)
Balanced equilibrium
c)
Subclinical conditions
d)
Full-blown clinical cases
16.
All are pathogenic mechanism of an invading BACTERIA, except:
a)
Invading and multiply in the infected body part
b)
Production of toxin or poison
c)
Hypersensitivity response
d)
Send genetic material to the nucleus
17.
Human's Carrier State:
The patient develops chronic infection and transmit infection for a long period of time - over 1 year
The patient develops chronic infection and transmit infection for a long period of time - over 1 year
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
18.
Human's Carrier State:
The patient recovered from an acute illness may continue to shed the organism
The patient recovered from an acute illness may continue to shed the organism
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
19.
Human's Carrier State:
The patient transmit the infection shortly before they become symptomatic
The patient transmit the infection shortly before they become symptomatic
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
20.
Human's Carrier State:
The patient never develop symptoms of the disease
The patient never develop symptoms of the disease
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
21.
Human's Carrier State:
Example - Hepatitis A virus
Example - Hepatitis A virus
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
22.
Human's Carrier State:
Example - Chicken pox
Example - Chicken pox
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
23.
Human's Carrier State:
Example - Shigella
Example - Shigella
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
24.
Human's Carrier State:
Example - Hepatitis B virus and HIV
Example - Hepatitis B virus and HIV
a)
Subclinical carriers
b)
Incubatory carriers
c)
Convalescent carriers
d)
Chronic carriers
25.
Host's portal of entry/exit:
Via buccal cavity and saliva down to the GI route
Via buccal cavity and saliva down to the GI route
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
26.
Host's portal of entry/exit:
Via expectoration, sneezing and coughing
Via expectoration, sneezing and coughing
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
27.
Host's portal of entry/exit:
Via urine and genital secrtions
Via urine and genital secrtions
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
28.
Host's portal of entry/exit:
Via percutaneous route by insect bites and needles
Via percutaneous route by insect bites and needles
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
29.
Host's portal of entry/exit:
Example - impetigo, syphilis and chickenpox
Example - impetigo, syphilis and chickenpox
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
30.
Host's portal of entry/exit:
Example - rabies virus, HAV
Example - rabies virus, HAV
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
31.
Host's portal of entry/exit:
Example - Leptospirae, STIs
Example - Leptospirae, STIs
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
32.
Host's portal of entry/exit:
Example - influenza virus, M. tuberculosis
Example - influenza virus, M. tuberculosis
a)
Respiratory tract
b)
Genitourinary tract
c)
Alimentary tract
d)
Skin
33.
Host's portal of entry/exit:
Example - rubella, cytomegalovirus, syphilis
Example - rubella, cytomegalovirus, syphilis
a)
In-utero transmission
b)
Genitourinary tract
c)
Alimentary tract
d)
Respiratory tract
34.
Host's portal of entry/exit:
Via placenta while the fetus is developing
Via placenta while the fetus is developing
a)
In-utero transmission
b)
Genitourinary tract
c)
Alimentary tract
d)
Respiratory tract
35.
General factors of resistance:
Eliminating harmful agent via GI tract
Eliminating harmful agent via GI tract
a)
Gastric Juices
b)
Diarrhea
c)
Normal Bacterial Flora
d)
Cough Reflex
36.
General factors of resistance:
The susceptible host prevents pathogenic organisms from growing.
The susceptible host prevents pathogenic organisms from growing.
a)
Gastric Juices
b)
Diarrhea
c)
Normal Bacterial Flora
d)
Cough Reflex
37.
A specialized mucus-secreting epithelial membrane that lines the interior surface of the eyeball.
a)
Conjuctiva
b)
Lacrimal Fluid
c)
Lysozymes
d)
Pupil
38.
Action of the immune system for delayed hypersensitivity and regulation of antibody production
a)
Cell-mediated immunity
b)
Circulationg antibodies
39.
Action of the immune system where it inactivate specific antigens or organisms and prevent replication in the body
a)
Cell-mediated immunity
b)
Circulationg antibodies
40.
The host develops long-lasting antibodies to fight infection
a)
Active immunity
b)
Passive immunity
41.
It results from either natural disease or vaccines
a)
Active immunity
b)
Passive immunity
42.
It normally takes several weeks of exposure or immunization before protective antibodies are produced.
a)
Active immunity
b)
Passive immunity
43.
The antibodies are given to the host where it provides immediate protection.
a)
Active immunity
b)
Passive immunity
44.
It is activated if immune serum globulin is given shortly after exposure.
a)
Active immunity
b)
Passive immunity
45.
Binds to surfaces components of S. aureus, Strep.
a)
Fibronectin
b)
Beta-Lysine
c)
Interferons
d)
Tumor-Necrosis Factor
46.
Kills g+ bacteria by disrupting the plasma membrane
a)
Fibronectin
b)
Beta-Lysine
c)
Interferons
d)
Tumor-Necrosis Factor
47.
Produced in response to virus infection
a)
Fibronectin
b)
Beta-Lysine
c)
Interferons
d)
Tumor-Necrosis Factor
48.
Examples are:
Cachetin, Lymphotoxin & Bacteriocins
Cachetin, Lymphotoxin & Bacteriocins
a)
Fibronectin
b)
Beta-Lysine
c)
Interferons
d)
Tumor-Necrosis Factor
49.
Levels of Disease Prevention:
It is applied in the pre-pathogenesis phase
It is applied in the pre-pathogenesis phase
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
50.
Levels of Disease Prevention:
good habits of health and hygiene
good habits of health and hygiene
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
51.
Levels of Disease Prevention:
proper and prompt utilization of available health and medical facilities
proper and prompt utilization of available health and medical facilities
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
52.
Levels of Disease Prevention:
proper sewage disposal
proper sewage disposal
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
53.
Levels of Disease Prevention:
Increasing the resistance of the possible host
Increasing the resistance of the possible host
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
54.
Levels of Disease Prevention:
Segregation of the reservoir
Segregation of the reservoir
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
55.
Levels of Disease Prevention:
It is applied in the pathogenesis period
It is applied in the pathogenesis period
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
56.
Levels of Disease Prevention:
Early detection and prompts treatment of diseases
Early detection and prompts treatment of diseases
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
57.
Levels of Disease Prevention:
Screening programs like Papsmear, primary medical care
Screening programs like Papsmear, primary medical care
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
58.
Levels of Disease Prevention:
It emphasizes a person’s remaining abilities and attempts to restore the person to as normal a life as possible
It emphasizes a person’s remaining abilities and attempts to restore the person to as normal a life as possible
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
59.
Levels of Disease Prevention:
Intensive, periodic follow-up and treatment
Intensive, periodic follow-up and treatment
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
60.
Levels of Disease Prevention:
Disability limitation
Disability limitation
a)
Primary Level
b)
Secondary Level
c)
Tertiary Level
100 %
